SEC 13F Intelligence

BIOTECH ACQUISITION COMPANY

CUSIP G1125A116

Biotech Acquisition Company has 1 institutional holders in Filings Flow’s 13F database, together reporting 0 shares worth $0 as of Q2 2025.

Institutional Holders
1
Q2 2025
Reported Value
$0
Ticker
unmapped
private placement or foreign
Quarters Tracked
18

Ownership Trend

Institutional holders
Q1 ’21: 18Q1 ’21Q2 ’21: 30Q3 ’21: 34Q4 ’21: 50Q4 ’21Q1 ’22: 47Q2 ’22: 42Q3 ’22: 44Q3 ’22Q4 ’22: 42Q1 ’23: 1Q2 ’23: 1Q2 ’23Q3 ’23: 1Q4 ’23: 1Q1 ’24: 1Q1 ’24Q2 ’24: 1Q3 ’24: 1Q4 ’24: 1Q4 ’24Q1 ’25: 1Q2 ’25: 1filingsflow.com
Total reported value
Q1 ’21: $2MQ1 ’21Q2 ’21: $4MQ3 ’21: $4MQ4 ’21: $5MQ4 ’21Q1 ’22: $2MQ2 ’22: $824,000Q3 ’22: $403,000Q3 ’22Q4 ’22: $414,901Q1 ’23: $0Q2 ’23: $0Q2 ’23Q3 ’23: $0Q4 ’23: $0Q1 ’24: $0Q1 ’24Q2 ’24: $0Q3 ’24: $0Q4 ’24: $0Q4 ’24Q1 ’25: $0Q2 ’25: $0filingsflow.com

Holders

··
Export to Excel
Manager% of PortfolioValueSharesQuarter
CONCOURSE FINANCIAL GROUP SECURITIES, INC.$0 AUM—$00Q2 2025

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.